The Stratus® CS Acute Care™ NT-proBNP assay is an in vitro diagnostic test for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) in heparinized plasma. In individuals suspected of having CHF, measurements of NT-proBNP are used as an aid in diagnosis and the assessment of severity. The test is further indicated for the risk stratification of patients with acute coronary syndrome and heart failure, resulting from left-ventricular dysfunction.
Measurements of NT-proBNP are used as an aid in the diagnosis of individuals suspected of having congestive heart failure (CHF). Other potential clinical uses of NT-proBNP are risk stratification of patients with acute coronary syndrome (ACS) and CHF, as well as treatment and monitoring in patients with left ventricular dysfunction (LVD).
NT-proBNP |
|
Assay Range |
15 – 20,000 pg/mL |
Sensitivity |
15.0 pg/mL |
Reproducibility (CV) |
4.4% at 96.6 pg/mL |
Calibration Stability |
30 days |
DilPak™ Automatic Dilution |
Yes |
Sodium Heparin Tubes |
Yes |
Lithium Heparin Tubes |
Yes |
Loading...
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community Supported by Siemens Healthineers
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
What Do We Know About XBB.1.5?
The XBB.1.5 variant is a new sub-variant of Omicron. It has been identified... Read more
Major Healthcare Impacts of COVID-19
“Health at a Glance: Europe 2022” outlines the impact of the pandemic... Read more
Ten High-Income Countries Report the Effects of COVID-19 Burnout on Primary Care Physicians
According to a new report from the Commonwealth Fund, the COVID-19 pandemic... Read more
JOIN OUR MANAGEMENT COMMUNITY